Stock EXPN BIOT
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders EXPN BIOT Nasdaq Stockholm

Equities

SE0008348262

End-of-day quote Nasdaq Stockholm
Other stock markets
- PTS - Intraday chart for EXPN BIOT
16/05 ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
16/04 ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ExpreS2ion Biotech Holding AB Announces Changes to Leadership Team
CI
ExpreS2ion Biotech Names Chief Scientific Officer
MT
ExpreS2ion Biotech Holding AB Appoints Dr. Farshad Guirakhoo as Chief Scientific Officer, Effective January 16, 2023
CI
ExpreS2ion Biotech Holding AB Announces Resignation of Allan Rosetzsky from the Board of Directors
CI
ExpreS2ion Biotech Holding AB Appoints Mattis F. Ranthe as New Chief Medical Officer, Effective February 1, 2022
CI
ExpreS2ion Biotech Holding AB Announces Board Changes
CI
ExpreS2ion Biotech Holding AB Announces Resignation of Gitte L. Pedersen from the Board of Directors
CI
ExpreS2ion Biotech Holding AB Announces Management Changes
CI
Expres2ion Biotech Holding AB Appoints Keith Alexander as New Chief Financial Officer, Effective October 1, 2020
CI
ExpreS2ion Biotechnologies Announces Change in Chief Executive Officer
CI
ExpreS2ion Biotech Holding AB Re-Appoints Mazars Set Revisionsbyrå AB as Auditor
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXPRS2 Stock
  4. Stock
  5. News EXPN BIOT
  6. Insiders